← back to search

Natalie E. Dean

Emory University · US
Area of research
Infectious Diseases · Modeling and Simulation
Research interest
Research interests include COVID-19 epidemiological studies, SARS-CoV-2 and COVID-19 Research, Vaccine Coverage and Hesitancy, and Viral Infections and Outbreaks Research.
h-index
38
citations
9,186
works
139
NIH funding
primary concept
Medicine
email

Recent publications

Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case-control study.
2026cited by 2position: contributordoi
Integrating Genomic Data into Test-negative Designs for Estimating Lineage-specific COVID-19 Vaccine Effectiveness.
2026cited by 1position: contributordoi
Making infectious disease data local and as accessible as the weather forecast.
2026cited by 0position: contributordoi
Infectious disease modeling for public health practice: projections, scenarios, and uncertainty in three phases of outbreak response.
2026cited by 0position: contributordoi
Novel Representations of Vaccine Protection Against Progression to Severe Disease Over Time
2026cited by 0position: contributordoi
Effectiveness of the TAK-003 dengue vaccine in adolescents during the 2024 outbreak in São Paulo, Brazil: a test-negative, case–control study
The Lancet Infectious Diseases 2025cited by 8position: middledoi
Estimation of Lassa fever incidence rates in West Africa: Development of a modeling framework to inform vaccine trial design.
2025cited by 2position: contributordoi
Randomized Trial of Targeted Indoor Spraying to Prevent Aedes-Borne Diseases.
2025cited by 1position: contributordoi
Integrating genomic data into test-negative designs for estimating lineage-specific COVID-19 vaccine effectiveness
2025cited by 1position: contributordoi
Estimating COVID-19 vaccine effectiveness among children and adolescents using data from a school-based weekly COVID-19 testing program.
2025cited by 0position: contributordoi
Analysis methods for covariate-constrained cluster randomized trials with time-to-event outcomes.
2025cited by 0position: contributordoi
Poor vaccine responders mask the true trend in vaccine effectiveness against progression to severe disease.
2025cited by 0position: contributordoi
Predictability of infectious disease outbreak severity: Chikungunya as a case study.
2025cited by 0position: contributordoi
Different antigenic distance metrics generate similar predictions of influenza vaccine response breadth despite moderate correlation.
2025cited by 0position: contributordoi
Sprint-Intensity Arm Interval Training May Improve Cardiorespiratory Fitness and Cardiometabolic Health Among Children With Mobility Disabilities: Case Report.
2025cited by 0position: contributordoi
Different antigenic distance metrics generate similar predictions of influenza vaccine response breadth despite moderate correlation
2025cited by 0position: contributordoi
Infectious disease modeling for public health practice: projections, scenarios, and uncertainty in three phases of outbreak response
2025cited by 0position: contributordoi
Test-Negative Study Designs for Evaluating Vaccine Effectiveness.
2024cited by 12position: contributordoi
Effectiveness of the fourth dose of COVID-19 vaccines against severe COVID-19 among adults 40 years or older in Brazil: a population-based cohort study.
2024cited by 4position: contributordoi
Hypothesis testing and sample size considerations for the test-negative design.
2024cited by 2position: contributordoi
Methods for the estimation of direct and indirect vaccination effects by combining data from individual- and cluster-randomized trials.
2024cited by 2position: contributordoi
Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV
Vaccine X 2024cited by 1position: middledoi
Workshop on the design and use of clinical trials with multiple endpoints, with a focus on prevention of RSV.
2024cited by 1position: contributordoi
The TIRS trial: Enrollment procedures and baseline characterization of a pediatric cohort to quantify the epidemiologic impact of targeted indoor residual spraying on Aedes-borne viruses in Merida, Mexico.
2024cited by 1position: contributordoi
Severity-dependent test-seeking behaviors and test-negative designs: impact on estimated vaccine effectiveness and utility of analytic and design choices.
2024cited by 1position: contributordoi
Estimation of Lassa fever incidence rates in West Africa: development of a modeling framework to inform vaccine trial design
2024cited by 0position: contributordoi
Estimating the impact of COVID-19 vaccine inequities: a modeling study
Nature Communications 2023cited by 101position: middledoi
Estimating the impact of COVID-19 vaccine inequities: a modeling study.
2023cited by 64position: contributordoi
Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants
BMC Infectious Diseases 2023cited by 56position: lastdoi
Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants.
2023cited by 34position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 36 papers (2019–2026)Ira M. Longini · University of Florida22 papers (2015–2024)M. Elizabeth Halloran · University of Washington22 papers (2019–2025) · 13 papers (2019–2025)Albert I. Ko · Universidad de Antioquia12 papers (2021–2026)Jason R. Andrews · Stanford University11 papers (2022–2026)Otavio Ranzani · Addenbrooke's Hospital11 papers (2021–2026)Marco Ajelli · Indiana University Bloomington10 papers (2020–2022) · 9 papers (2019–2024)Alessandro Vespignani · University of Colorado System9 papers (2020–2022)Stefano Merler · Fondazione Bruno Kessler7 papers (2020–2021) · 7 papers (2020–2022)Ana Pastore y Piontti · University of Colorado System7 papers (2020–2021)Matteo Chinazzi · University of Massachusetts Amherst7 papers (2020–2022) · 7 papers (2020–2022)Julio Croda · Fundação Oswaldo Cruz6 papers (2021–2024)Nicola Perra · Queen Mary University of London5 papers (2020–2023)Alex Pentland · Moscow Institute of Thermal Technology5 papers (2020–2022)Alessandro Vespignani · Northeastern University5 papers (2020–2023)Matteo Chinazzi · Northeastern University4 papers (2020–2023)